Category: Biotech

Biotech, Industry

Genetic Engineering Across the Tree of Life

September 21, 2020

Via: Genetic Engineering and Biotechnology News

Industrial bioengineering is now using genetically modified microbes to produce a wide array of products at industrial scale, including everything from biofuels to nutraceuticals such as resveratrol. But despite the diversity of output, the primary organisms producing them are modified […]

Biotech, Industry

A new biotech forms to revive Amgen’s old heart drug

August 26, 2020

Via: Biopharma Dive

It wasn’t that long ago that CETP inhibitors were the next big thing in heart medicine. The drugs were part of a bet by researchers that raising the levels of high-density lipoprotein (HDL), also known as “good” cholesterol, might be […]

Biotech, Industry

AI Can Aid Biopharma, but Industry Must Remember the Science

August 25, 2020

Via: Genetic Engineering and Biotechnology News

Artificial intelligence (AI) has huge potential in bioprocessing. Its ability to model process data in real-time and feed this information into automated control systems is attractive to efficiency-focused drug companies. According to a recent report, biopharma companies are warming to […]

Biotech, Clinical Trials, Industry, Research and Development

Gut Microbiome Influences B Cell and Antibody Repertoire

August 6, 2020

Via: Genetic Engineering and Biotechnology News

The influence that the gut microbiota has over the human body continues to expand in interesting ways. Seeing as the intestinal tract contains the largest concentration of immunological tissue (mucosa-associated lymphoid tissue or MALT) it seems logical that the microbial […]

Biotech, Industry

Trends in Bioprocess 4.0 and their Impact on Biomanufacturing

May 18, 2020

Via: Genetic Engineering and Biotechnology News

The biomanufacturing industry is currently undergoing a revolution in how it produces biopharmaceutical products. The driving force behind this paradigm shift is known as Bioprocess 4.0 or Industry 4.0. The approach focuses on how to apply data, predictive modeling, analytics, […]

Biotech, Industry, News

Biotechnology Market: Insights into how contours of market will change in coming years

May 8, 2020

Via: BioSpace

The global biotechnology market is mainly driven by the surge in the demand for food, depleting natural resources, government regulatory support, and technological advancements of various solutions to counter fatal diseases. The advent of stem cell technology, nanotechnology, and cloning […]

Biotech, Cell and Gene Therapy, Industry, News

Novel Antibiotics May Result from Bacterial Cell Wall Study

May 1, 2020

Via: Genetic Engineering and Biotechnology News

Scientists from the University of Leeds say they have identified a key process in the way bacteria protect themselves from attack and that their finding heralds a potential new strategy in the hunt for antibiotics. The researchers pieced together how […]

Biotech, Clinical Trials, Industry, Research and Development

Trial data help small biotech ready its anti-itch drug for approval

April 21, 2020

Via: Biopharma Dive

Cara’s hypothesis in developing Korsuva was that by acting on opioid receptors, the experimental drug could provide relief from itching without leading to addiction. Rather than stimulating the mu-opioid receptor, like morphine and other pain drugs with addictive potential, Korsuva […]

Biotech, Industry, Pricing, Regulations

Biotech stocks surge as people are ‘hungry’ for good news on the coronavirus

April 17, 2020


Biotech stocks surged Friday after new details on a closely watched clinical trial lifted hopes that scientists may be close to a treatment for the coronavirus, which continues to maintain its foothold across the globe after emerging a little over […]

Biotech, Clinical Trials, Industry, Research and Development, Vaccines

Designing precision antibiotics with inspiration from bacteria’s survival strategy

April 16, 2020

Via: FierceBiotech

Widely prescribed broad-spectrum antibiotics such as amoxicillin can kill off many types of bacteria indiscriminately, including harmless strains. But that can lead to resistance that bugs can pass on to other pathogenic bacteria. Compounds that target specific bacterial infections instead […]

Biotech, Industry

Better Antibodies for Bioprocessing

April 14, 2020

Via: Genetic Engineering and Biotechnology News

During R&D for a new bioprocess, a developer wants to know as much as possible about any therapeutic candidate. When it comes to monoclonal antibody (mAb)-based biotherapeutics, a bioprocessor wants to understand a mAb’s features. At Abveris, a contract research […]

Biotech, Industry

Commercial and regulatory strategy considerations for biotech

April 3, 2020

Via: Biopharma Dive

Many critical and innovative new therapies today, including those for rare and untreated diseases, are in the biotech pipeline. In fact, today biotech represents more than 80 percent of the drugs currently in development. However, careful planning at the earliest […]